A solemn bell-ringing ceremony marked the start of trading at the Budapest Stock Exchange (BSE) this Monday – the occasion was the public listing of Naturland Holding. The event was attended by Richárd Végh, CEO of the Budapest Stock Exchange, and Tibor Ásványi, founder of Naturland, among others. With this issue, the company has listed […]
It was 150 years ago, on September 23, 1872 that a well-known pioneer of the Hungarian pharmaceutical industry, Gedeon Richter was born. Today, the Budapest-based company bearing his name is present in 50 countries of the world. In 1901, Gedeon Richter bought the Sas Pharmaceutical Factory in Budapest, where he set up a laboratory for […]
In the second quarter of this year, the Hungarian pharmaceutical company Gedeon Richter's sales and profit exceeded analysts' expectations: sales increased by 23.7% to HUF 192.9 billion and profit after tax more than doubled to HUF 77.1 billion in April-June compared to the same period last year, the company said on the website of the […]
As part of the continuation of a series of large-scale developments since 2019, leading pharmaceutical giant Egis Gyógyszergyár Plc. now invests EUR 21.1 million in Körmend, W Hungary to install new technology, increase capacity and enhance efficiency. The investment is set to help the company not only produce more but also adapt to rapidly changing […]
Gedeon Richter Plc. and Searchlight Pharma Inc. have announced that Searchlight has assumed all Canadian distribution and promotional activities for Evra®, a transdermal contraceptive patch. This transition, which covers regulatory, distribution and promotional responsibilities in Canada, stems from the acquisition of ex-US rights to the Evra brand by Richter from Janssen Pharmaceutica NV, a wholly-owned […]
AbbVie and Gedeon Richter Plc. have announced a new co-development and license agreement to research, develop and commercialize novel dopamine receptor modulators for the potential treatment of neuropsychiatric diseases. The collaboration is based on the results of preclinical research carried out by Richter and includes several new chemical entities selected for development. AbbVie and Richter […]
AbbVie, the partner company of the Hungarian pharmaceutical firm Gedeon Richter Plc., has submitted a supplemental New Drug Application (sNDA) for cariprazine (VRAYLAR®) to the U.S. Food and Drug Administration (FDA) for the adjunctive treatment of major depressive disorder (MDD) in patients who are receiving ongoing antidepressant therapy. The submission is supported by results from […]
It was announced this late November that Ceva Phylaxia will set up a new vaccine factory along with the associated infrastructure by developing a new site under a greenfield investment in Hungary. As the General Manager of the company, Dr. Zsolt Németh tells Diplomacy&Trade, Ceva Phylaxia is growing and planning to grow. “Investments related to […]
Early this year, the French multinational healthcare company Sanofi announced the establishment of EUROAPI, a future leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients (API). The standalone company will combine Sanofi’s API commercial and development activities with six of its European production sites, one of which is in Újpest, […]
One of the largest companies in the healthcare industry, Roche Hungary Ltd., known for its innovative solutions, has signed a strategic cooperation agreement with the Hungarian government. The aim of the agreement is to use Roche's value-based healthcare model to multiply the innovative and personalized therapies delivered to patients in a way that significantly reduces […]
“Sales revenues in the first nine months were up on a year-on-year basis in most markets in both HUF and EUR terms, fueled by growth in the specialty portfolio, in particular higher Vraylar® and Evra® royalties. This broad-based strength in revenue performance was translated into a solid bottomline also ex-Vraylar®, despite higher spending on R&D […]
In order to increase their pharmaceutical production capacity, the French-owned Egis Pharmaceuticals has expanded its site in Körmend. With the investment of more than EUR 21.8 million, in addition to the new packaging factory, Egis has also established a plant with special know-how and technological needs, typically suitable for the production of oncology products; thereby […]
Important changes ahead in the life of the Swiss Roche Group's Hungarian subsidiary: a new managing director, Raffella Bondi has arrived at the helm of the company, which will continue its operations in the Budapest One office building. In parallel to the move, the pharmaceutical company is also moving to an agile organizational model. With […]
The decline in sales of some contraceptives, the absence of major acquisitions and the exchange rate movements reduced the profit at the Hungarian pharmaceutical company Gedeon Richter Plc. The after-tax profit of Gedeon Richter Plc. fell by 9.3% to HUF 54.9 billion in the first half of this year. Yet the company's revenue rose to […]
The Hungarian pharmaceutical firm Gedeon Richter Plc. announced this Monday that it signed a multi-party agreement to divest its wholesale operation to Grin-Farm S.R.L. and its retail operations to BIRIVOFARM S.R.L., both in the Republic of Moldova. Richter as a majority owner of both the wholesale and the retail operations is entitled to approximately 62% […]
